Medicare delayed a plan to make insurance companies cover GLP-1 drugs Wegovy and Zepbound. Instead, Medicare will cover the popular weight-loss drugs ...
ABC7 San Francisco: Eli Lilly to sell Zepbound directly to consumers without insurance coverage
People who are in need of weight loss medications but do not have insurance coverage will soon have a new way to access one of the popular medications, Zepbound. Eli Lilly, the maker of Zepbound, ...
Insurance coverage of blockbuster obesity drugs has been spotty at best over the years, and it looks like things are getting worse, not better. Plans are dropping coverage or restricting it further.
That opens the door for broader access to Zepbound, which is not currently covered by Medicare and many other insurance plans for weight loss. Demand for the injection has soared over the last year ...
Little Rock Public Radio: Spotty insurance coverage for GLP-1 drugs gets worse
Insurance may cover Zepbound (tirzepatide) depending on your plan and the specific condition being treated. To determine whether your plan covers Zepbound, contact your insurance provider directly. If ...
The roughly $1,000 monthly price tag of Eli Lilly's weight loss drug Zepbound put the blockbuster treatment out of reach for Willow Baillies, 29, whose insurance does not cover it. Baillies, a human ...
Twelve million people lost coverage for Zepbound over the last year. The same number of people lost coverage for Wegovy, according to an analysis by GoodRx, a drug discount website.
NBC Bay Area: Medicare can now cover Eli Lilly's Zepbound for sleep apnea, Health Department agency says